RhumbLine Advisers’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,291
| Closed | -$1.58K | – | 4228 |
|
|
2024
Q2 | $1.58K | Hold |
1,291
| – | – | ﹤0.01% | 4204 |
|
|
2024
Q1 | $2.81K | Hold |
1,291
| – | – | ﹤0.01% | 4054 |
|
|
2023
Q4 | $2K | Hold |
1,291
| – | – | ﹤0.01% | 4092 |
|
|
2023
Q3 | $1.67K | Hold |
1,291
| – | – | ﹤0.01% | 4128 |
|
|
2023
Q2 | $2.22K | Buy |
+1,291
| New | +$2.22K | ﹤0.01% | 4203 |
|
|
2022
Q2 | – | Sell |
-67,376
| Closed | -$180K | – | 3124 |
|
|
2022
Q1 | $180K | Buy |
67,376
+428
| +0.6% | +$1.14K | ﹤0.01% | 2782 |
|
|
2021
Q4 | $290K | Sell |
66,948
-985
| -1% | -$4.27K | ﹤0.01% | 2716 |
|
|
2021
Q3 | $346K | Buy |
67,933
+3,757
| +6% | +$19.1K | ﹤0.01% | 2706 |
|
|
2021
Q2 | $406K | Buy |
64,176
+3,190
| +5% | +$20.2K | ﹤0.01% | 2656 |
|
|
2021
Q1 | $471K | Buy |
60,986
+1,845
| +3% | +$14.2K | ﹤0.01% | 2521 |
|
|
2020
Q4 | $387K | Buy |
59,141
+3,310
| +6% | +$21.7K | ﹤0.01% | 2550 |
|
|
2020
Q3 | $371K | Sell |
55,831
-7,790
| -12% | -$51.8K | ﹤0.01% | 2427 |
|
|
2020
Q2 | $530K | Buy |
63,621
+2,956
| +5% | +$24.6K | ﹤0.01% | 2315 |
|
|
2020
Q1 | $465K | Sell |
60,665
-1,690
| -3% | -$13K | ﹤0.01% | 2193 |
|
|
2019
Q4 | $518K | Buy |
62,355
+1,147
| +2% | +$9.53K | ﹤0.01% | 2341 |
|
|
2019
Q3 | $452K | Buy |
61,208
+921
| +2% | +$6.8K | ﹤0.01% | 2368 |
|
|
2019
Q2 | $676K | Buy |
60,287
+2,500
| +4% | +$28K | ﹤0.01% | 2238 |
|
|
2019
Q1 | $621K | Sell |
57,787
-1,356
| -2% | -$14.6K | ﹤0.01% | 2236 |
|
|
2018
Q4 | $893K | Buy |
59,143
+21,402
| +57% | +$323K | ﹤0.01% | 2064 |
|
|
2018
Q3 | $698K | Buy |
37,741
+689
| +2% | +$12.7K | ﹤0.01% | 2148 |
|
|
2018
Q2 | $847K | Buy |
37,052
+8,100
| +28% | +$185K | ﹤0.01% | 2086 |
|
|
2018
Q1 | $824K | Buy |
28,952
+200
| +0.7% | +$5.69K | ﹤0.01% | 2027 |
|
|
2017
Q4 | $607K | Sell |
28,752
-4,245
| -13% | -$89.6K | ﹤0.01% | 2159 |
|
|
2017
Q3 | $600K | Buy |
32,997
+480
| +1% | +$8.73K | ﹤0.01% | 2221 |
|
|
2017
Q2 | $504K | Buy |
32,517
+10,607
| +48% | +$164K | ﹤0.01% | 2300 |
|
|
2017
Q1 | $378K | Buy |
21,910
+872
| +4% | +$15K | ﹤0.01% | 2384 |
|
|
2016
Q4 | $231K | Buy |
21,038
+3,812
| +22% | +$41.9K | ﹤0.01% | 2615 |
|
|
2016
Q3 | $270K | Buy |
17,226
+2,300
| +15% | +$36.1K | ﹤0.01% | 2534 |
|
|
2016
Q2 | $152K | Buy |
+14,926
| New | +$152K | ﹤0.01% | 2830 |
|